BDBM50162774 ABT-199 US11420968, Example ABT-199 Venetoclax
US8969336, 577 US8969336, 547 US11512074, Example T-9 Gilteritinib BDBM144315
- King, HM; Rana, S; Kubica, SP; Mallareddy, JR; Kizhake, S; Ezell, EL; Zahid, M; Naldrett, MJ; Alvarez, S; Law, HC; Woods, NT; Natarajan, A Aminopyrazole based CDK9 PROTAC sensitizes pancreatic cancer cells to venetoclax. Bioorg Med Chem Lett 43: (2021)
- Discovery of a Covalent Inhibitor That Overcame Resistance to Venetoclax in AML Cells Overexpressing BFL-1.
- Design, synthesis, and biological activity evaluation of novel HDAC3 selective inhibitors for combination with Venetoclax against acute myeloid leukemia.
- An imidazo[1,2-a]pyridine-pyridine derivative potently inhibits FLT3-ITD and FLT3-ITD secondary mutants, including gilteritinib-resistant FLT3-ITD/F691L.